Clinical Outcome of Breast Cancer Occurring after Treatment for Hodgkin's Lymphoma: Case-Control Analysis
El-Din, Mohamed A Alm
Raad, Rita A
Goldberg, Saveli I
MetadataShow full item record
CitationEl-Din, Mohamed A. Alm, Kevin S. Hughes, Rita A. Raad, Saveli I. Goldberg, Alan C. Aisenberg, Andrzej Niemierko, and Alphonse G. Taghian. 2009. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: Case-control analysis. Radiation Oncology 4:19.
AbstractBackground: To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin's lymphoma (HL). Methods: 39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis. Results: The median age at diagnosis of HL and BC was 25.3 and 45.3 years, respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%) had bilateral disease. Mode of detection of the index breast cancers was by mammographic screening in 17 patients (60.7%), palpable lump in 8 patients (28.6%), clinical examination in two patients (7.1%), and unknown in one patient (3.6%). Case-control analysis showed that histological features and prognosis of BC after HL were similar to those of primary BC, however, for BC after HL, mastectomy was the predominant surgery (P = .001) and adjuvant radiotherapy and anthracycline-based chemotherapy were less frequently used as compared to primary BC (P < .001 and .003, respectively). Conclusion: The previous history of HL does not appear to be a poor prognostic factor for BC occurring thereafter.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:10243426
- HMS Scholarly Articles